Literature DB >> 9470003

Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program.

M K Hunter1, S H Mandel, D E Sesser, R S Miyabira, L Rien, M R Skeels, S H LaFranchi.   

Abstract

OBJECTIVES: To determine the type and frequency of thyroid disorders detected in infants with low thyroxine (T4) and nonelevated thyroid-stimulating hormone (TSH) screening test results in the Northwest Regional Newborn Screening Program (NWRNSP) over the 20-year period from May 1975 to May 1995 and to determine the effect of follow-up of these infants on the overall recall rate. STUDY
DESIGN: The NWRNSP requests a serum specimen in infants with an absolute T4 level < 38.6 nmol/L (< 3 mg/dl) and in infants with two filter paper T4 concentrations less than the 3%, regardless of the TSH concentration. We conducted a retrospective analysis of infants who were followed up because of low T4 and nonelevated TSH concentrations on newborn screening. To determine the effect of follow-up of infants with low T4 levels, nonelevated TSH concentrations on the recall rate, we selected 1 year (1994) for review. Serum sample requests were evaluated to determine the reason for the request.
RESULTS: Over this 20-year period, the NWRNSP detected 450 infants with primary hypothyroidism among 1,747,805 infants screened (1:3,884). Of these, 416 were detected on the basis of low T4 levels and nonelevated TSH screening test results, whereas an additional 34 infants with primary hypothyroidism and 29 infants with hypopituitary hypothyroidism were detected as a result of follow-up of low T4 levels and nonelevated TSH screening test results. This included 25 infants with delayed TSH rise (1:67,226), 9 infants with mild hypothyroidism (TSH levels < 25 mU/L) (1:194,212), 29 infants with hypopituitary hypothyroidism (1:60,269), and 434 infants with T4-binding globulin deficiency (1:4,027). Excluding those with T4-binding globulin deficiency, the false-positive rate was 43.5:1. This compares with an overall false-positive rate of 12:1 for our screening program.
CONCLUSION: Follow-up of infants with low T4 and nonelevated TSH concentration on screening led to the detection of 63 additional infants with hypothyroidism, for an overall frequency of 1:27,743. We believe this yield justifies continued follow-up of infants with low T4 levels, nonelevated (TSH) screening test results in our program.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9470003     DOI: 10.1016/s0022-3476(98)70487-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Hypothyroidism in Down syndrome: screening guidelines and testing methodology.

Authors:  Olga Hardy; Gordon Worley; Mary M Lee; Shu Chaing; Joanne Mackey; Blythe Crissman; Priya Sunil Kishnani
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

2.  Single newborn screen or routine second screening for primary congenital hypothyroidism.

Authors:  Stuart K Shapira; Cynthia F Hinton; Patrice K Held; Elizabeth Jones; W Harry Hannon; Jelili Ojodu
Journal:  Mol Genet Metab       Date:  2015-08-11       Impact factor: 4.797

Review 3.  Newborn screening strategies for congenital hypothyroidism: an update.

Authors:  Stephen H LaFranchi
Journal:  J Inherit Metab Dis       Date:  2010-03-02       Impact factor: 4.982

4.  Congenital Central Hypothyroidism due to a Homozygous Mutation in the TSHβ Subunit Gene.

Authors:  Sarah Catharina Grünert; Miriam Schmidts; Joachim Pohlenz; Matthias Volkmar Kopp; Markus Uhl; Karl Otfried Schwab
Journal:  Case Rep Pediatr       Date:  2011-12-21

Review 5.  Congenital hypothyroidism.

Authors:  Pankaj Agrawal; Rajeev Philip; Sanjay Saran; Manish Gutch; Mohd Sayed Razi; Puspalata Agroiya; Keshavkumar Gupta
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

6.  Central Congenital Hypothyroidism Detected by Neonatal Screening in Sapporo, Japan (2000-2004): It's Prevalence and Clinical Characteristics.

Authors:  Fumie Fujiwara; Kaori Fujikura; Koji Okuhara; Jyunko Tsubaki; Masaru Fukushi; Kozo Fujita; Kenji Fujieda; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2008-08-08

7.  Determining Reference Ranges for Total T4 in Dried Blood Samples for Newborn Screening.

Authors:  Anna-Isabella Hijman; Daniel Konrad; Ralph Fingerhut
Journal:  Int J Neonatal Screen       Date:  2020-03-04

8.  Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.

Authors:  Xinwen Huang; Dingwen Wu; Lin Zhu; Wenjun Wang; Rulai Yang; Jianbin Yang; Qunyan He; Bingquan Zhu; Ying You; Rui Xiao; Zhengyan Zhao
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

9.  Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision).

Authors:  Keisuke Nagasaki; Kanshi Minamitani; Makoto Anzo; Masanori Adachi; Tomohiro Ishii; Kazumichi Onigata; Satoshi Kusuda; Shohei Harada; Reiko Horikawa; Masanori Minagawa; Haruo Mizuno; Yuji Yamakami; Masaru Fukushi; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2015-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.